Literature DB >> 12135711

The prognostic significance of Gail model risk factors for women with breast cancer.

Paul Ian Tartter1, Csaba Gajdos, Sharon Rosenbaum Smith, Alison Estabrook, Alfred W Rademaker.   

Abstract

BACKGROUND: Because many risk factors for breast cancer are related to hormonal factors and hormonal factors influence breast cancer prognosis, risk factors may have prognostic value. In order to assess the prognostic value of risk factors for breast cancer we divided patients with breast cancer into those at high risk and low risk using the Gail model.
METHODS: Patients with available follow-up and information concerning age, age at menarche, number of children, age at first birth, number of first degree relatives with breast cancer, and number of previous breast biopsies were divided into low and high-risk groups by the average relative risk calculated using the Gail model. Risk factors, clinical presentations, pathologic findings, tumor characteristics, extent of disease, treatment and outcomes for the 106 high-risk women were compared with the 206 low-risk women. Stage IV patients were excluded.
RESULTS: The average relative risk of breast cancer was 2.09. The 106 high-risk women were significantly older (58 years versus 53 years; P = 0.001), older at first live birth (30 years versus 23 years; P <0.001), more likely to have a first degree relative with breast cancer (57% versus 0%; P <0.001), and more likely to have previously had a breast biopsy (19% versus 1%; P <0.001). There was no difference in the average age at menarche. Low-risk patients were significantly more frequently nulliparous (40% versus 22%; P = 0.002). Clinical presentation, pathologic findings, extent of disease, and treatment were comparable in high and low-risk patients. Cancers of low-risk patients were more frequently poorly differentiated (39% versus 25%, P = 0.044). Tamoxifen was used more frequently in high-risk patients (56% versus 41%; P = 0.012). High-risk patients exhibited significantly better 5-year (95% versus 88%; P = 0.047) and 10-year distant disease-free survival than low-risk patients (88% versus 79%; P = 0.050). In multivariate analysis only the number of involved lymph nodes was related to local (P = 0.001) and distant (P <0.001) disease-free survival.
CONCLUSIONS: Breast cancer patients considered high risk by the Gail model have significantly better disease-free survival than low-risk patients. This study does not support the notion that risk factors for breast cancer are prognostic factors.

Entities:  

Mesh:

Year:  2002        PMID: 12135711     DOI: 10.1016/s0002-9610(02)00885-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Multiple births and breast cancer prognosis: a population based study.

Authors:  Lukman Thalib; Suhail A R Doi; Per Hall
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.

Authors:  Norbert W Paul; Mita Banerjee; Susanne Michl
Journal:  J Community Genet       Date:  2013-11-08

3.  Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.

Authors:  Ellen T Chang; Roger L Milne; Kelly-Anne Phillips; Jane C Figueiredo; Meera Sangaramoorthy; Theresa H M Keegan; Irene L Andrulis; John L Hopper; Pamela J Goodwin; Frances P O'Malley; Nayana Weerasooriya; Carmel Apicella; Melissa C Southey; Michael L Friedlander; Graham G Giles; Alice S Whittemore; Dee W West; Esther M John
Journal:  Breast Cancer Res Treat       Date:  2008-11-26       Impact factor: 4.872

4.  The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer.

Authors:  Chantal C Orgéas; Per Hall; Lena U Rosenberg; Kamila Czene
Journal:  Breast Cancer Res       Date:  2008-12-16       Impact factor: 6.466

5.  Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.

Authors:  Mark E Sherman; Laura Ichikawa; Ruth M Pfeiffer; Diana L Miglioretti; Karla Kerlikowske; Jeffery Tice; Pamela M Vacek; Gretchen L Gierach
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.